DELIVERING BEST-IN-CLASS CBRNE CAPABILITIES TO ENSURE THE NATION’S SAFETY AND SECURITY
Our nation’s homeland security, defense and intelligence leaders face increasingly sophisticated adversaries with deadly chemical, biological, radiological, nuclear and explosive (CBRNE) weapons. At Noblis, we know that developing leading-edge capabilities to detect, attribute, deter, respond to and prevent terrorist attacks is key to the security of our nation’s future. Noblis is uniquely equipped to model, assess, analyze, predict, characterize and deter the full range of CBRNE threats. This complex mission relies on our forward-thinking, sustainable solutions to improve threat awareness, enhance surveillance and detection, and deploy effective countermeasures.
Emerging CBRNE threats in today’s context of evolving budgetary and national priorities complicates the challenge. Noblis aligns scientific proficiency, unique tools and advanced technologies with our intimate understanding of our federal customers’ mission needs to leverage solutions and deliver new and improved capabilities in defense preparedness. We work side-by-side with government leaders, maximizing budget outcomes and optimizing performance to support this increasingly complex and challenging mission.
Noblis’ industry-leading CBRNE experts provide critical program support for our nation’s readiness, response and resilience in all cases of potential adversary attacks. From strategy planning and analysis through programmatic and logistical support, the Noblis approach is built on a foundation of technical excellence that enhances ongoing efforts to maintain and advance state-of-the-art defense innovation.
Noblis’ 25 years of thought leadership, responsiveness, and mission focus on CBRNE defense equips us with the unique expertise and insight our federal clients seek. Our proficient coordination and implementation of research, development, testing and evaluation (RDT&E) facilitates independent verification and validation (IV&V) of the efficiency and effectiveness of CBRNE defense capabilities throughout the full-range technology development lifecycle.
Noblis’ threat intelligence experts, systems engineers and scientists work at the leading edge to analyze, assess and model our adversaries’ evolving motives and capabilities, and provide the tools to defeat threats through precision risk assessment, vulnerability analysis and threat characterization.
Noblis is an industry leader in developing world-class bioinformatics tools to support our nation’s rapidly evolving biosurveillance needs. Our bioinformatics expertise uses big data, advanced analytics and high-performance computing to create a layered defense against adversaries deploying biological weapons. Customized Noblis-designed bioinformatics tools for metagenomic analysis are utilized to detect, define, deter and defeat biological threats.
Noblis leverages data fusion and analytics tools, including simulation, modeling, and knowledge management systems, to support all aspects of the CBRNE mission. We work in close collaboration with our government customers to develop unbiased and strategic technical solutions that are robust, practical, affordable, and innovative. Noblis develops agile solutions that deliver on our customers’ missions today while building sustainable foundations for success tomorrow.
BioVelocity is a bioinformatics tool based on an innovative algorithm and approach to genomic reference indices. Using a fast and accurate hashing algorithm, BioVelocity can quickly align reads to a set of references. BioVelocity takes advantage of supercomputer power —resulting in faster speeds, increased functionality, increased throughput, and improved accuracy over current technologies. The supercomputing enables us to use a brute force index, built out of all possible base pair sequences of various k-mer lengths. This index is used to map against thousands of references and allows for quick alignment of the k-mers amongst them simultaneously.
BioVelocity has a variety of functions that the user can choose from, including SNP detection, metagenomic analysis, conserved/signature sequence detection, and compression.
To learn more about Noblis BioVelocity, contact us here.
As sequencing costs drop and thousands of new complete genomes are added to public repositories every year, the landscape of ground truth for current bacterial and viral organisms is in constant flux. Many PCR assays currently used to detect agents and foodborne pathogens were designed years ago, which means they are limited by the availability of genomic data at the time of their inception. Could there be a way to use newer genomic information to ensure that your current assays are still performing as expected?
Noblis developed a tool called the PCR Signature Erosion Tool (PSET). PSET tests PCR assays in silico against the latest versions of NCBI’s sequence databases to determine if they still match only to their intended targets.
To learn more about Noblis PSET, contact us here.